JP2013230157A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013230157A5 JP2013230157A5 JP2013139604A JP2013139604A JP2013230157A5 JP 2013230157 A5 JP2013230157 A5 JP 2013230157A5 JP 2013139604 A JP2013139604 A JP 2013139604A JP 2013139604 A JP2013139604 A JP 2013139604A JP 2013230157 A5 JP2013230157 A5 JP 2013230157A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- use according
- pharmaceutical composition
- dosage form
- tag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 9
- 239000002552 dosage form Substances 0.000 claims 7
- 108010002231 IgA-specific serine endopeptidase Proteins 0.000 claims 6
- 101500014188 Haemophilus influenzae Immunoglobulin A1 protease Proteins 0.000 claims 2
- 208000010159 IgA glomerulonephritis Diseases 0.000 claims 2
- 206010021263 IgA nephropathy Diseases 0.000 claims 2
- 101710135898 Myc proto-oncogene protein Proteins 0.000 claims 2
- 102100038895 Myc proto-oncogene protein Human genes 0.000 claims 2
- 101710150448 Transcriptional regulator Myc Proteins 0.000 claims 2
- 230000037396 body weight Effects 0.000 claims 2
- 235000014304 histidine Nutrition 0.000 claims 2
- 150000002411 histidines Chemical class 0.000 claims 2
- 239000007928 intraperitoneal injection Substances 0.000 claims 2
- 238000001990 intravenous administration Methods 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45305503P | 2003-03-07 | 2003-03-07 | |
| US60/453,055 | 2003-03-07 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010270964A Division JP2011101645A (ja) | 2003-03-07 | 2010-12-03 | ＩｇＡ１沈着症の治療 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015024975A Division JP2015096079A (ja) | 2003-03-07 | 2015-02-12 | ＩｇＡ１沈着症の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013230157A JP2013230157A (ja) | 2013-11-14 |
| JP2013230157A5 true JP2013230157A5 (https=) | 2013-12-26 |
Family
ID=33418058
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006509132A Expired - Lifetime JP5438886B2 (ja) | 2003-03-07 | 2004-03-05 | ＩｇＡ１沈着症の治療 |
| JP2010270964A Withdrawn JP2011101645A (ja) | 2003-03-07 | 2010-12-03 | ＩｇＡ１沈着症の治療 |
| JP2013139604A Pending JP2013230157A (ja) | 2003-03-07 | 2013-07-03 | ＩｇＡ１沈着症の治療 |
| JP2015024975A Pending JP2015096079A (ja) | 2003-03-07 | 2015-02-12 | ＩｇＡ１沈着症の治療 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006509132A Expired - Lifetime JP5438886B2 (ja) | 2003-03-07 | 2004-03-05 | ＩｇＡ１沈着症の治療 |
| JP2010270964A Withdrawn JP2011101645A (ja) | 2003-03-07 | 2010-12-03 | ＩｇＡ１沈着症の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015024975A Pending JP2015096079A (ja) | 2003-03-07 | 2015-02-12 | ＩｇＡ１沈着症の治療 |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US7407653B2 (https=) |
| EP (1) | EP1603511B1 (https=) |
| JP (4) | JP5438886B2 (https=) |
| KR (2) | KR20130026513A (https=) |
| CN (1) | CN1777673B (https=) |
| AT (1) | ATE496992T1 (https=) |
| CA (1) | CA2558873C (https=) |
| DE (1) | DE602004031199D1 (https=) |
| ES (1) | ES2360291T3 (https=) |
| WO (1) | WO2004096157A2 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5438886B2 (ja) * | 2003-03-07 | 2014-03-12 | タフツ メディカル センター インコーポレイテッド | ＩｇＡ１沈着症の治療 |
| US8440191B2 (en) | 2005-11-18 | 2013-05-14 | Tufts Medical Center | Clearance of abnormal IGA1 in IGA1 deposition diseases |
| US20080027554A1 (en) * | 2006-07-31 | 2008-01-31 | Talmadge Karen D | Kit and methods of treatment of an intervertebral disc |
| TW201040266A (en) * | 2009-04-10 | 2010-11-16 | Biomarin Pharm Inc | Methods of enhancing yield of active IgA protease |
| US8841109B2 (en) | 2009-04-20 | 2014-09-23 | The University Of Kansas | IGA1 protease polypeptide agents and uses thereof |
| CN104073474A (zh) * | 2014-06-27 | 2014-10-01 | 樊均明 | 一种IgA1酶及其制备方法和应用 |
| WO2017223534A2 (en) * | 2016-06-24 | 2017-12-28 | Anthera Pharmaceuticals, Inc. | Methods of treating iga nephropathy and henoch-schönlein purpura nephritis using a b-cell activating factor (baff) inhibitor |
| CN115197328B (zh) * | 2021-04-09 | 2025-05-16 | 北京大学第一医院 | 一种可清除体内免疫球蛋白A的重组融合蛋白酶及其制备方法和在治疗IgA肾病中的应用 |
| IL314384A (en) * | 2022-01-29 | 2024-09-01 | Univ Peking First Hospital | Truncated forms of IGA protease, fusion proteins containing a truncated form of IGA protease and uses thereof |
| WO2024102466A2 (en) | 2022-11-11 | 2024-05-16 | Igan Biosciences | Iga protease polypeptide agents |
| WO2025183146A1 (ja) * | 2024-02-29 | 2025-09-04 | 積水メディカル株式会社 | 免疫学的測定方法、免疫学的測定用試薬、免疫学的測定用検体前処理液、免疫学的測定用試薬キット、及び非特異反応抑制剤 |
| WO2025237369A1 (en) * | 2024-05-15 | 2025-11-20 | Shanghai Alezyme Pharmaceuticals Ltd. | Conjugates comprising iga protease or variants thereof and a polyethylene glycol moiety, and uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
| US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
| US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
| US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
| US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
| DK130889A (da) * | 1989-03-17 | 1990-09-18 | Mogens Kilian | Immunoglobulin a1-proteaser (iga1-proteaser), fremgangsmaade til genteknologisk fremstilling af saadanne enzymer samt vaccine indeholdende enzymerne og fragmenter deraf til immunisering mod bakteriel meningitis og andre sygdomme fremkaldt af iga1-protease-producerende bakterier |
| ATE396399T1 (de) * | 1998-03-31 | 2008-06-15 | Asahi Kasei Pharma Corp | Verfahren zur untersuchung der iga-nephropathie |
| ATE421976T1 (de) | 1999-05-18 | 2009-02-15 | Dyax Corp | Fab fragmentbibliotheken und verfahren für deren verwendung |
| JP5438886B2 (ja) * | 2003-03-07 | 2014-03-12 | タフツ メディカル センター インコーポレイテッド | ＩｇＡ１沈着症の治療 |
-
2004
- 2004-03-05 JP JP2006509132A patent/JP5438886B2/ja not_active Expired - Lifetime
- 2004-03-05 CA CA2558873A patent/CA2558873C/en not_active Expired - Lifetime
- 2004-03-05 KR KR1020137005608A patent/KR20130026513A/ko not_active Ceased
- 2004-03-05 CN CN2004800062159A patent/CN1777673B/zh not_active Expired - Lifetime
- 2004-03-05 DE DE602004031199T patent/DE602004031199D1/de not_active Expired - Lifetime
- 2004-03-05 AT AT04749338T patent/ATE496992T1/de not_active IP Right Cessation
- 2004-03-05 WO PCT/US2004/006615 patent/WO2004096157A2/en not_active Ceased
- 2004-03-05 KR KR1020057016464A patent/KR20060015468A/ko not_active Ceased
- 2004-03-05 ES ES04749338T patent/ES2360291T3/es not_active Expired - Lifetime
- 2004-03-05 EP EP04749338A patent/EP1603511B1/en not_active Expired - Lifetime
- 2004-08-19 US US10/921,676 patent/US7407653B2/en not_active Expired - Lifetime
-
2008
- 2008-07-21 US US12/177,132 patent/US20090130084A1/en not_active Abandoned
- 2008-07-21 US US12/177,125 patent/US8216568B2/en not_active Expired - Lifetime
-
2010
- 2010-12-03 JP JP2010270964A patent/JP2011101645A/ja not_active Withdrawn
-
2013
- 2013-07-03 JP JP2013139604A patent/JP2013230157A/ja active Pending
-
2015
- 2015-02-12 JP JP2015024975A patent/JP2015096079A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013230157A5 (https=) | ||
| JP2012144538A5 (https=) | ||
| TWD179359S (zh) | 藥物注射裝置之部分（五） | |
| IL235020A0 (en) | History of n-phenylbenzenesulfonamide, pharmaceutical preparations containing them and their use in the preparation of medicines | |
| IL232764A (en) | Fluoromethyl6,5 - Dihydro - 4 H - [3,1] Oxazines, Pharmaceuticals Containing Them and Their Use in the Preparation of Medicines to Treat Alzheimer's Disease | |
| MX2015010083A (es) | Nanoparticulas biodegradables y clinicamente compatibles como portadores para administracion de farmacos. | |
| WO2015048498A3 (en) | Carrier-free biologically-active protein nanostructures | |
| JP2011516606A5 (https=) | ||
| PH12015500374A1 (en) | Extended release compositions of an aminoalkyl nitrate | |
| JP2016523943A5 (https=) | ||
| JP2016528283A5 (https=) | ||
| PH12015501313A1 (en) | Chloroprocaine-based pharmaceutical composition for repeated intrathecal administration | |
| MX2011005899A (es) | Composicion farmacéutica con antihistamínico no sedante y combinaciones. | |
| TH93529B (th) | ชิ้นส่วนอุปกรณ์จ่ายยาแบบสูด | |
| CN302482374S (zh) | 药品包装盒(头孢克洛颗粒) | |
| CN302041178S (zh) | 瓶体 | |
| UA100374C2 (ru) | Лекарственное средство в виде порошка в саше с муколитическими и отхаркивающими свойствами | |
| CN302199354S (zh) | 药瓶(顺妥敏) | |
| CN302482372S (zh) | 药品包装盒(注射用盐酸丙帕他莫) | |
| CN302121186S (zh) | 药品包装盒（克比热提片） | |
| TR201005911A2 (tr) | Geliştirilmiş dissolüsyon profiline sahip bir ilaç formülasyonu. | |
| RU2012126428A (ru) | Способ получения микрокапсул лекарственных препаратов группы цефалоспоринов в альбумине человеческом сывороточном | |
| CN302412321S (zh) | 药盒（三维b片） | |
| CN302230034S (zh) | 药品包装盒(曲安奈德鼻喷雾剂2) | |
| CN302297562S (zh) | 药品包装盒（葡萄糖注射液） |